| Financial Year |
March 31 2023 |
| Monetary Funds |
7,041,449,692.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
421,936,020.32 |
| Accounts Receivable |
26,947,140,863.81 |
| Advances to Suppliers |
1,736,059,311.89 |
| Other Receivables |
2,533,359,219.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,520,067,279.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,834,090,109.13 |
| Other Current Assets |
1,140,098,752.74 |
| Total Current Assets |
81,832,477,711.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,903,576,715.71 |
| Long-term Equity Investment |
1,613,338,449.82 |
| Investment Properties |
357,008,354.59 |
| Fixed Assetes |
2,774,442,062.99 |
| Under-construction Projects |
161,806,586.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,262,713,820.02 |
| R&D expenses |
-- |
| Goodwill |
180,473,025.23 |
| Long-Term Deferred and Prepaid Expenses |
64,771,462.29 |
| Deferred Income Tax Assets |
1,237,445,890.54 |
| Other Non-Current Assets |
7,066,756,834.58 |
| Sub-Total of Non-Current Assets |
28,893,259,975.34 |
| Total Assets |
110,725,737,686.92 |
| Short-Term Loans |
9,866,833,887.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
802,560,059.19 |
| Accounts Payable |
56,612,083,070.45 |
| Accounts Received In Advance |
15,688,266.05 |
| Employee Compensation Payable |
306,139,752.16 |
| Taxes Payable |
696,130,021.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,772,584,827.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,669,790,813.83 |
| Other Current Liabilities |
4,746,008,275.61 |
| Sub-Total of Current Liabilities |
90,771,368,808.62 |
| Long-term Loans |
9,798,420,414.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
246,847,807.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
25,086,579.51 |
| Deferred Income Tax Liabilities |
9,844,213.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,369,665,572.14 |
| Total Liabilities |
101,141,034,380.76 |
| Paid-In Capital(Or Share Stock) |
1,081,340,098.00 |
| Capital Surplus |
908,389,307.33 |
| Surplus Reserve |
272,415,076.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,430,143,362.67 |
| Minority Stockholder's Interest |
2,007,241,754.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,577,461,551.93 |
| Owner's Equity（Stockholder's Equity） |
9,584,703,306.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
110,725,737,686.92 |
